Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on September 10, 2026

Sep. 10, 2026

BC3 Technologies Announces First Retail Availability of SEAL Hemostatic Wound Spray at Army & Air Force Exchange Service Locations

Indeterminate GlobeNewswire

Sep. 10, 2026

MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026

Indeterminate GlobeNewswire

Sep. 10, 2026

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

Indeterminate GlobeNewswire

Sep. 10, 2026

NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026

Indeterminate GlobeNewswire

Sep. 10, 2026

Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences

Indeterminate GlobeNewswire

Sep. 10, 2026

Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors

Indeterminate GlobeNewswire

Sep. 10, 2026

Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule

Indeterminate GlobeNewswire

Sep. 10, 2026

Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

Indeterminate GlobeNewswire

Sep. 10, 2026

Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event

Indeterminate GlobeNewswire

Sep. 10, 2026

ORYZON to Participate in Upcoming Events in September and October

Indeterminate GlobeNewswire

Sep. 10, 2026

Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases

Indeterminate GlobeNewswire

Sep. 10, 2026

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Indeterminate GlobeNewswire

Sep. 10, 2026

Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

Indeterminate GlobeNewswire

Sep. 10, 2026

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Indeterminate GlobeNewswire

Sep. 10, 2026

SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 10, 2026

IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire